Thromboxane B2

• 

  Subject Areas on Research

  • A role for the thromboxane receptor in L-NAME hypertension. 
  • Altered inflammatory responses in leukotriene-deficient mice. 
  • Antiplatelet Effect Durability of a Novel, 24-Hour, Extended-Release Prescription Formulation of Acetylsalicylic Acid in Patients With Type 2 Diabetes Mellitus. 
  • Antiplatelet effects of aspirin with phytosterols: comparison with non-enteric coated aspirin alone. 
  • Aspirin Resistance in healthy drug-naive men versus women (from the Heredity and Phenotype Intervention Heart Study). 
  • Aspirin resistance. 
  • Assessment of platelet activity by measuring platelet-derived substances in plasma from patients with acute myocardial infarction: surprising lessons from the GUSTO-III Platelet Study. 
  • Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. 
  • Cardiopulmonary effects of tumor necrosis factor-alpha in the piglet: influence of cyclooxygenase inhibition. 
  • Cardiovascular changes in group B streptococcal sepsis in the piglet: response to indomethacin and relationship to prostacyclin and thromboxane A2. 
  • Cell-cell interactions and bronchoconstrictor eicosanoid reduction with inhaled carbon monoxide and resolvin D1. 
  • Chronic thromboxane inhibition preserves function of rejecting rat renal allografts. 
  • Chronic thromboxane synthase inhibition with CGS 12970 in human cyclosporine nephrotoxicity. 
  • Conditions influencing the interaction of asialo von Willebrand factor with human platelets--the effects of external ionized calcium concentration and the role of arachidonate pathway. 
  • Could coenzyme Q10 affect hemostasis by inhibiting platelet vitronectin (CD51/CD61) receptor? 
  • Deficiency of 5-lipoxygenase accelerates renal allograft rejection in mice. 
  • Deficient thromboxane synthesis and response in platelets from premature infants. 
  • Effect of dietary fish oil supplementation on eicosanoid production by rat renal allografts. 
  • Effect of low-dose aspirin on thromboxane production and the antihypertensive effect of captopril. 
  • Effects of a leukotriene antagonist on the early hemodynamic manifestations of group B streptococcal sepsis in piglets. 
  • Effects of a novel Mac-1 inhibitor, NPC 15669, on hemostatic parameters during preconditioned myocardial infarction. 
  • Effects of cardiopulmonary bypass on eicosanoid metabolism during pediatric cardiovascular surgery. 
  • Effects of pulmonary static inflation with 50% xenon on oxygen impairment during cardiopulmonary bypass for stanford type A acute aortic dissection: A pilot study. 
  • Eicosanoids and the hemodynamic course of live Escherichia coli-induced sepsis in baboons. 
  • Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. 
  • Evidence that pretransplant donor blood transfusion prevents rat renal allograft dysfunction but not the in situ cellular alloimmune or morphologic manifestations of rejection. 
  • Evidence that renal prostaglandin and thromboxane production is stimulated in chronic cyclosporine nephrotoxicity. 
  • Hemostatic changes after early versus late intracoronary magnesium during acute myocardial infarction in swine. 
  • Hydrocortisone treatment of early SIRS in acute experimental pancreatitis. 
  • In vitro effects of acetaminophen and its analogues on human platelet aggregation and thromboxane B2 synthesis. 
  • Increased formation of thromboxane in vivo in humans with mastocytosis. 
  • Intravillous eicosanoid compartmentalization and regulation of placental blood flow. 
  • Mac-1 inhibitor affects certain hemostatic parameters during myocardial stunning in swine. 
  • Pertussis toxin attenuates platelet-activating factor-induced pulmonary hemodynamic alterations in pigs. 
  • Pharmacokinetics and biochemical efficacy of pirmagrel, a thromboxane synthase inhibitor, in renal allograft recipients. 
  • Physiologic role for enhanced renal thromboxane production in murine lupus nephritis. 
  • Plasma and amniotic fluid prostacyclin and thromboxane in mild pregnancy-induced hypertension. 
  • Plasma thromboxane and prostacyclin are linear related and increased in patients presenting with acute myocardial infarction. 
  • Platelet activation and pneumonia: is soluble p-selectin the right marker? 
  • Prostacyclin protects against elevated blood pressure and cardiac fibrosis. 
  • Relation of fish oil supplementation to markers of atherothrombotic risk in patients with cardiovascular disease not receiving lipid-lowering therapy. 
  • Role of lipid-derived mediators in tumor necrosis factor-induced endothelin-1 release in vivo. 
  • Role of platelet activating factor in kidney transplant rejection in the rat. 
  • Serial changes of the plasma prostanoids during myocardial ischemia-reperfusion in swine. Effects of magnesium, diltiazem, and a novel Mac-1 inhibitor. 
  • Statin therapy and inflammation in patients with diabetes treated with high dose aspirin. 
  • Statin therapy and thromboxane generation in patients with coronary artery disease treated with high-dose aspirin. 
  • The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study. 
  • The effect of salmeterol on nocturnal symptoms, airway function, and inflammation in asthma. 
  • The effect of zinc deficiency and food restriction on prostaglandin E2 and thromboxane B2 in saliva and plasma of rats. 
  • The role of leukotrienes in the late hemodynamic manifestations of group B streptococcal sepsis in piglets. 
  • Thromboxane synthetase inhibition improves function of hydronephrotic rat kidneys.